Medical Dynamometer Market

Executive Summary

Medical Dynamometer Market was valued at US $520.66 million in 2021 and is projected to grow at 4.92% CAGR over the forecast period to reach US $694.46 million by 2027. Medical Dynamometer Market represented US $47.67 million opportunity over 2019-2021 and estimated to create US $173.81 million opportunity in 2027 over 2021.

Medical Dynamometer from Consainsights analyses the Medical Dynamometer Market in the Life Sciences industry over the forecast period to 2027.

Medical Dynamometer research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Dynamometer segmentation includes Product, Application, Usage and Geography.

Based on the Product, the Medical Dynamometer analysis covers Chest Dynamometer, Hand Dynamometer, Push Pull Dynamometer, Squeeze Dynamometer, Other Devices.

In Product segment, Chest Dynamometer segment has highest cagr growth of 4.36%.

Based on the Application, the Medical Dynamometer analysis covers Orthopedic, Neurology, Cardiology, Medical Trauma, Others.

In Application segment, Orthopedic segment has highest cagr growth of 4.36%.

Based on the Usage, the Medical Dynamometer analysis covers Hospitals/Clinics, Rehabilitation Centers, Others.

In Usage segment, Hospitals/Clinics segment has highest cagr growth of 4.36%.

Based on the region, the Medical Dynamometer analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include JTECH Medical Industries Inc., KERN and SOHN GmbH, Charder Electronic Co, Ltd., Marsden Weighing Group, Biodex Medical Systems, Inc., Fabrication Enterprises, North Coast Medical, Lafayette Instrument and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Chest Dynamometer segment has the highest revenue of US $193.73 million and is expected to grow at CAGR of 4.36% by 2027 Chest Dynamometer segment has highest cagr growth of 4.36%.

Chest Dynamometer

Chest Dynamometer segment was valued at US $175.99 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $258.40 million by 2027. Chest Dynamometer segment represented US $17.74 million opportunity over 2019-2021 and estimated to create US $64.67 million opportunity in 2027 over 2021.

Hand Dynamometer

Hand Dynamometer segment was valued at US $131.35 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $192.86 million by 2027. Hand Dynamometer segment represented US $13.24 million opportunity over 2019-2021 and estimated to create US $48.27 million opportunity in 2027 over 2021.

Push Pull Dynamometer

Push Pull Dynamometer segment was valued at US $84.73 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $124.40 million by 2027. Push Pull Dynamometer segment represented US $8.54 million opportunity over 2019-2021 and estimated to create US $31.13 million opportunity in 2027 over 2021.

Squeeze Dynamometer

Squeeze Dynamometer segment was valued at US $61.21 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $89.87 million by 2027. Squeeze Dynamometer segment represented US $6.17 million opportunity over 2019-2021 and estimated to create US $22.49 million opportunity in 2027 over 2021.

Other Devices

Other Devices segment was valued at US $19.71 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $28.93 million by 2027. Other Devices segment represented US $1.99 million opportunity over 2019-2021 and estimated to create US $7.24 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Orthopedic segment has the highest revenue of US $211.36 million and is expected to grow at CAGR of 4.36% by 2027 Orthopedic segment has highest cagr growth of 4.36%.

Orthopedic

Orthopedic segment was valued at US $192.01 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $281.92 million by 2027. Orthopedic segment represented US $19.35 million opportunity over 2019-2021 and estimated to create US $70.56 million opportunity in 2027 over 2021.

Neurology

Neurology segment was valued at US $119.68 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $175.72 million by 2027. Neurology segment represented US $12.06 million opportunity over 2019-2021 and estimated to create US $43.98 million opportunity in 2027 over 2021.

Cardiology

Cardiology segment was valued at US $73.51 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $107.93 million by 2027. Cardiology segment represented US $7.41 million opportunity over 2019-2021 and estimated to create US $27.01 million opportunity in 2027 over 2021.

Medical Trauma

Medical Trauma segment was valued at US $67.24 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $98.72 million by 2027. Medical Trauma segment represented US $6.78 million opportunity over 2019-2021 and estimated to create US $24.71 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $20.55 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $30.17 million by 2027. Others segment represented US $2.07 million opportunity over 2019-2021 and estimated to create US $7.55 million opportunity in 2027 over 2021.

Usage

Introduction

In 2021, Hospitals/Clinics segment has the highest revenue of US $220.75 million and is expected to grow at CAGR of 4.36% by 2027 Hospitals/Clinics segment has highest cagr growth of 4.36%.

Hospitals/Clinics

Hospitals/Clinics segment was valued at US $200.54 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $294.44 million by 2027. Hospitals/Clinics segment represented US $20.21 million opportunity over 2019-2021 and estimated to create US $73.69 million opportunity in 2027 over 2021.

Rehabilitation Centers

Rehabilitation Centers segment was valued at US $154.50 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $226.85 million by 2027. Rehabilitation Centers segment represented US $15.57 million opportunity over 2019-2021 and estimated to create US $56.77 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $117.95 million in 2019 and is projected to grow at 4.36% CAGR over the forecast period to reach US $173.18 million by 2027. Others segment represented US $11.89 million opportunity over 2019-2021 and estimated to create US $43.34 million opportunity in 2027 over 2021.